Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teodora Kolarova

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Oncology Reports|March 23, 2021
The Role of Patient Support Groups in Neuroendocrine NeoplasmsTeodora Kolarova, Catherine Bouvier
Clinical Chemistry|December 30, 2025
Circulating Clues: The Role of Cell-free DNA in Contemporary Prenatal ScreeningYoshiko Mito, Teodora Kolarova, Raj Shree, et al.
Obstetrics and Gynecology|February 3, 2023
Reconsidering Race Adjustment in Prenatal Alpha-Fetoprotein ScreeningR Nicholas Burns, Teodora Kolarova, Ronit Katz, et al.
Obstetrics and Gynecology|July 24, 2023
In ReplyR Nicholas Burns, Teodora Kolarova, Ronit Katz, et al.
Pancreas|March 23, 2017
Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United StatesEdward M Wolin, John Leyden, Grace Goldstein, et al.
Journal of Neuroendocrinology|June 8, 2023
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN surveyJorge Hernando, Teodora Kolarova, Chris Verslype, et al.
Research Involvement and Engagement|February 3, 2022
Co-creating with patients an impact framework across the medicine's life cycle: a qualitative study exploring patients' experiences of involvement in and perceptions of impact measuresOleks Gorbenko, Pascale Cavillon, Rachel H Giles, et al.
American Journal of Perinatology|August 29, 2024
The Effect of Self-Reported Race on Noninvasive Prenatal Screening Test CharacteristicsAnjali N Mitra, Aleksei Dingel, Teodora Kolarova, et al.
Journal of Global Oncology|July 19, 2017
Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETsSimron Singh, Dan Granberg, Edward Wolin, et al.
Advances in Therapy|August 12, 2023
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine TumoursJens Otto L Jørgensen, Wouter W de Herder, Wendy A Martin, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Oncology Reports|March 23, 2021
The Role of Patient Support Groups in Neuroendocrine NeoplasmsTeodora Kolarova, Catherine Bouvier
Clinical Chemistry|December 30, 2025
Circulating Clues: The Role of Cell-free DNA in Contemporary Prenatal ScreeningYoshiko Mito, Teodora Kolarova, Raj Shree, et al.
Obstetrics and Gynecology|February 3, 2023
Reconsidering Race Adjustment in Prenatal Alpha-Fetoprotein ScreeningR Nicholas Burns, Teodora Kolarova, Ronit Katz, et al.
Obstetrics and Gynecology|July 24, 2023
In ReplyR Nicholas Burns, Teodora Kolarova, Ronit Katz, et al.
Pancreas|March 23, 2017
Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United StatesEdward M Wolin, John Leyden, Grace Goldstein, et al.
Journal of Neuroendocrinology|June 8, 2023
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN surveyJorge Hernando, Teodora Kolarova, Chris Verslype, et al.
Research Involvement and Engagement|February 3, 2022
Co-creating with patients an impact framework across the medicine's life cycle: a qualitative study exploring patients' experiences of involvement in and perceptions of impact measuresOleks Gorbenko, Pascale Cavillon, Rachel H Giles, et al.
American Journal of Perinatology|August 29, 2024
The Effect of Self-Reported Race on Noninvasive Prenatal Screening Test CharacteristicsAnjali N Mitra, Aleksei Dingel, Teodora Kolarova, et al.
Journal of Global Oncology|July 19, 2017
Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETsSimron Singh, Dan Granberg, Edward Wolin, et al.
Advances in Therapy|August 12, 2023
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine TumoursJens Otto L Jørgensen, Wouter W de Herder, Wendy A Martin, et al.
Pageof 3